# 2 Ablative RadioTherapy Treatments for Prostate Cancer

> **NCT04654338** · PHASE2,PHASE3 · RECRUITING · sponsor: **Sunnybrook Health Sciences Centre** · enrollment: 30 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** SABR + HDR

## Key facts

- **NCT ID:** NCT04654338
- **Lead sponsor:** Sunnybrook Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-07-29
- **Primary completion:** 2024-01-29
- **Final completion:** 2028-07-29
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04654338

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04654338, "2 Ablative RadioTherapy Treatments for Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04654338. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*